scispace - formally typeset
J

Jill P. Smith

Researcher at Georgetown University

Publications -  119
Citations -  4133

Jill P. Smith is an academic researcher from Georgetown University. The author has contributed to research in topics: Pancreatic cancer & Gastrin. The author has an hindex of 35, co-authored 109 publications receiving 3665 citations. Previous affiliations of Jill P. Smith include Penn State Milton S. Hershey Medical Center & University of Washington.

Papers
More filters
Journal ArticleDOI

Common genetic variants in the CLDN2 and PRSS1-PRSS2 loci alter risk for alcohol-related and sporadic pancreatitis

David C. Whitcomb, +201 more
- 01 Dec 2012 - 
TL;DR: Two associations at genome-wide significance identified and replicated at PRSS1-PRSS2 and X-linked CLDN2 are reported and could partially explain the high frequency of alcohol-related pancreatitis in men.
Journal ArticleDOI

Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer.

Alison P. Klein, +132 more
TL;DR: The largest pancreatic cancer GWAS to date, including 9040 patients and 12,496 controls of European ancestry from the PANScan and the Pancreatic Cancer Case Control Consortium (PanC4), was performed in this paper.
Journal ArticleDOI

Effects of Gastrin, Proglumide, and Somatostatin on Growth of Human Colon Cancer

TL;DR: The findings suggest that growth of some human colon cancers may be hormone-dependent, and the effects of gastrin 17, proglumide, and somatostatin on growth were evaluated.
Journal ArticleDOI

Therapeutic Effect of Vitamin D Supplementation in a Pilot Study of Crohn's Patients

TL;DR: Twenty-four weeks supplementation with up to 5,000 IU/d vitamin D3 effectively raised serum 25(OH)D3 and reduced CDAI scores in a small cohort of Crohn's patients suggesting that restoration of normal vitamin D serum levels may be useful in the management of patients with mild–moderate Crohn’s disease.
Journal ArticleDOI

Treatment of chronic hepatitis C with amantadine.

TL;DR: Therapy with amantadine improved both biochemical and vrological markers in patients with hepatitis C who had previously not responded to treatment withinterferon.